Scientists say tests on animals suggest there may be a risk of people
catching the human form of BSE through blood transfusions, according to
reports.
Tests at the UK's Institute of Animal Health indicated that one in six
animals given blood from infected sheep appeared to develop the illness,
the Guardian newspaper says.
The study suggests red cells and plasma may have infectivity for vCJD -
the human form of BSE which destroys brain tissues - but the full version
of the research is not published until November.
Scientists have previously demonstrated transmission of BSE in animals,
but in animals fed infected brain.

The risk is very, very small in terms of catching vCJD through a
blood transfusion

|
|
Professor Hugh Pennington
|
The National Blood Service said the research was valuable, but stressed
there was no risk of contracting the disease by giving blood.
"We need to collect 10,000 units of blood a day to ensure lifesaving
treatments can continue. Therefore it is vital that donors keep giving
blood and that new donors keep coming forward," said a spokesman.
The study's authors suggest the risk of vCJD transmission through blood
may be "appreciable" where the government had previously described it as
"theoretical".
Precautions
The condition vCJD has claimed 114 victims in the UK, according to
figures released in January, with experts predicting cases will increase
by about 20% each year.
Professor Hugh Pennington, of Aberdeen University, said: "The worry is
that there are more people out there incubating the disease.
"We don't know how many people are going to come down with vCJD."
He said even if there were thousands more carrying vCJD, the risk of
catching it through a blood transfusion was "very, very small".
Prof Pennington said the transfusion risk was small
|
The government already has precautionary measures in place because of
the theoretical risk of transmission via transfusion.
For example, it imports plasma from abroad as white cells are thought
to be the element most likely to carry vCJD.
To date, there is no evidence of transmission from infected blood
transfusions, even though 22 people have received transfusions from eight
people who later contracted vCJD.
At present, there is no test for detecting vCJD in human blood. It is
thought one may become available next year.
Expert advisors are expected to make new recommendations on blood
transfusions within the next couple of months.
Future donors may be asked to take a test for vCJD before giving blood.
A Department of Health spokesman said: "These findings appear to
justify the precautionary approach taken by the Department of Health to
reduce the risk of vCJD transmission through blood and surgical
instruments."